Pfizer Inc.

We’re celebrating over 175 years of daring scientific innovation and we’re not done yet. Protect your health at

[Pfizer Inc. @pfizer]

Pfizer Chief Oncology Officer Jeff Legos joined @TIME CEO Jessica Sibley ahead of #ESMO26 to discuss the future of cancer care and the urgency behind oncology innovation.

Watch the conversation: https://t.co/oi4iiH1s4s

[Pfizer Inc. @pfizer]

Why do we weigh what we weigh? ⚖️

Season 7 of #ScienceWillWin explores the science behind #obesity—from hunger and hormones to genetics and real patient stories. Hosted by @DrJoeHanson of PBS's Be Smart. Coming soon.

🎧 Listen to the trailer today: https://t.co/yoWRZnWkaT

[Pfizer Inc. @pfizer]

This #BreastCancerAwarenessMonth, explore Moments Beyond Cancer — a new initiative highlighting small, everyday actions to help people with #MetastaticBreastCancer maintain a sense of self beyond their diagnosis: https://t.co/6B7YnKWkeQ

[Pfizer Inc. @pfizer]

Obesity isn’t a failure of willpower—it’s a chronic, multifactorial disease. Once weight is gained, the body works hard to keep it.

Pfizer’s Dr. Manige Konig on what the science now tells us: https://t.co/csuIpawatH

#Obesity #WeightStigma

[Pfizer Inc. @pfizer]

When Josh Raub was diagnosed with Hodgkin lymphoma at age 29, he wondered if he would ever have a family. Today, the father of two has been in complete remission for 12 years. He reflects on what matters most: https://t.co/id64yvVpte

[Pfizer Inc. @pfizer]

Finding participants is one of the biggest challenges in clinical research. #AI has the potential to help researchers identify potentially eligible volunteers faster, improve trial planning, and reduce administrative burden while keeping researchers and patients at the center of every decision.

Learn more: https://t.co/9sH8SY52QJ

[Pfizer Inc. @pfizer]

Meet the people behind the science.

This #WorldCancerResearchDay, our colleagues share what inspires them to advance cancer research and pursue breakthroughs that change patients’ lives.

[Pfizer Inc. @pfizer]

Empowerment starts with education. From understanding routine #ProstateCancer screenings to next steps after a diagnosis, knowledge can help clarify the path ahead. This #ProstateCancerAwarenessMonth, learn how to take an active role in care at https://t.co/5OR3CLPAis.

[Pfizer Inc. @pfizer]

When prostate cancer becomes resistant to traditional hormone therapies, new treatment approaches are needed.

Pfizer researchers are studying EZH2 and exploring ways to potentially reprogram treatment resistance in metastatic prostate cancer.

Learn more: https://t.co/35IqXhhy3H

[Pfizer Inc. @pfizer]

💊 Most people never question whether the medicine in their cabinet is real, but the illicit worldwide counterfeit drugs network is vast, adaptive, and relentless.

Here's how we’re helping combat counterfeits, disrupt criminal networks, and protect patients: https://t.co/giN5XWPdss

[Pfizer Inc. @pfizer]

What is one challenge in ATTR-CM you would like to highlight?

At #ESCCongress in Munich, leading clinicians in the field told us what they thought.

At Pfizer, we are committed to advancing understanding and awareness of ATTR-CM to improve outcomes for patients.

[Pfizer Inc. @pfizer]

As #ESCCongress 2026 returns to Munich, early diagnosis and treatment initiation remain the biggest opportunity to improve outcomes in ATTR-CM, an underdiagnosed cause of heart failure.

Explore how the landscape has evolved and what needs to happen next: https://t.co/pzodOzmLkN

[Pfizer Inc. @pfizer]

250 years of American innovation have shown what’s possible when different minds and ideas come together.

As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine.

#America250

[Pfizer Inc. @pfizer]

Every dose of medicine you take is the final step in a long journey—one that runs through qualified suppliers, rigorous testing, and continuous monitoring.

Pfizer's Bina Nair and Kenya Edmondson walk through what it takes to make sure every dose performs the same way, everywhere: https://t.co/jtyvMBN51X

#PharmaManufacturing #QualityAssurance

[Pfizer Inc. @pfizer]

For more than a century, scientists studied cancer as a caricature of healthy tissue. Spatial transcriptomics is changing that. Now, with the ability to map tumors cell by cell, researchers are rethinking what’s possible in cancer treatment.

Read more: https://t.co/13ies7udcU

#Oncology #CancerResearch #PrecisionMedicine

[Pfizer Inc. @pfizer]

Our global survey found unspoken compromises may persist in hemophilia care, pointing to a need for more open conversations. With 6 in 10 patients saying HCPs are their primary source of information on newer treatments, shared-decision making can help evolve care. See more: https://t.co/2ygb4aXGor

[Pfizer Inc. @pfizer]

Most scientific discoveries begin in a lab. Reaching patients requires something else entirely: a global system built to produce medicines consistently, at scale, without ever compromising on quality.

Read more: https://t.co/zE603gyNY0

#GlobalHealth #PatientAccess

[Albert Bourla @AlbertBourla]

Our second quarter results are out today, and I am proud to report another strong quarter of execution. Thank you to my @pfizer colleagues, all of you, for everything behind these results and for your commitment to our purpose: breakthroughs that change patients’ lives.

[Pfizer Inc. @pfizer]

Not all migraine attacks are random. Hormonal shifts across the menstrual cycle can trigger longer, more severe attacks. Here’s what the research reveals about menstrual migraine: https://t.co/JHkekCuZz9

#MigraineAwareness #HormoneHealth #WomensHealth

[Pfizer Inc. @pfizer]

“My daughter is my driving force. She’s what I’m truly living for.”

After a rare cancer diagnosis, Isis Kanevsky shares the lessons that ground her as she navigates treatment and survivorship. https://t.co/HGMSQBzVDy

#CancerSurvivorship #CancerAwareness #RareDisease